Back to Screener

Financial Services

Marex Group plc Ordinary Shares(MRX)

Live Price

Offline

$64.12

-1.11% today

Window Change

+21.83%

Window

May 5, 2026 โ†’ Jun 24, 2026

Market Cap
$3.78B
Revenue Growth
+25.4%
EPS Growth
+39.5%
Dividend Yield
1.1%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 35 bars ยท May 5, 2026 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Marex Group plc Ordinary Shares (MRX) is a Financial Services stock with a market cap of $3.78B and listed on NASDAQ. The stock last traded around $64.12 and up 21.8% across the available one-year price window (May 5, 2026 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +25.4%, EPS growth of +39.5%, a dividend yield of 1.1%. What stands out right now is revenue +25.4%, EPS +39.5%, free cash flow -42.8% with operating margin 32.0% and ROIC 2.5%. The dividend is present but secondary, with a yield around 1.1%. Valuation is more restrained than many high-expectation growth names at P/E 12.2 and price/sales 1.0. Stock Foundry combines MRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Benchmark Edge

MRX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

MRX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

MRX Max Drawdown

-12.45%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for MRX and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Marex Group plc Ordinary Shares (MRX)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$851.7M

-27.5% YoY

FY Net Income

$56.5M

-38.3% YoY

Free Cash Flow

$463.5M

+114.4% YoY

Revenue Growth

+25.4%

EPS Growth

+39.5%

Gross Margin

74.7%

Net Margin

8.5%

Income statement

USD

Annual
Metric20252024202320222021
Revenue3.6B2.9B2.4B1.2B852M
Gross Profit2.7B1.3B1.7B862M825M
Operating Income1.2B836M684M271M69M
EBITDA1.2B866M705M284M107M
Net Income308M218M128M92M57M
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

USD

Point-in-time
Metric20252024202320222021
Cash & Equivalents6.4B2.6B1.5B910M712M
Total Assets34.7B24.3B17.6B15.7B5.3B
Total Liabilities33.4B23.3B16.8B15.1B4.8B
Shareholder Equity1.3B977M776M678M478M
Total Debt10.2B6.1B5.4B5.7B1.3B
Net Debt3.8B3.6B3.9B4.8B578M

Cash flow positioning

Latest Full Year

Operating Cash Flow

471M

+108.7% YoY

Capital Expenditures

7M

+22.3% YoY

Free Cash Flow

464M

+114.4% YoY

Key ratios

  • Gross Margin

    74.7%

  • Operating Margin

    32.0%

  • Net Margin

    8.5%

  • ROE

    26.0%

  • Debt / Equity

    8.05x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.